Addictive Disorders

Psychiatric Clinics of North America

Volumn 27, Issue 4, 2004, Pages

  Miller, Norman S ^a   Brady, Kathleen T ^b  

^a Michigan State University   (United States)

^b Clin Neurosci 67 Pres St C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DEXAMPHETAMINE; DIAMORPHINE; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; METHADONE;

ADDICTION; COMORBIDITY; DRUG HALF LIFE; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MEDICAL ASSESSMENT; MENTAL DISEASE; NEUROBIOLOGY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; REVIEW; SCREENING; SCREENING TEST; SUBSTANCE ABUSE;

EID: 8844270076     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2004.07.005     Document Type: Editorial

References (28)

1. Anderson RN. Deaths: leading causes for 1999. National vital statistics reports. 2001. Hyattsville (MD), National Center for Health Statistics, volume 49, #11.
2. Office of Applied Studies. Drug Abuse Warning Network (DAWN) data. 1999. Substance Abuse and Mental Health Services Administration (SAMHSA).
3. J.M. McGinnis, and W.H. Foege Actual causes of death in the United States JAMA 270 18 1993 2207 2212
4. D.A. Regier, W.E. Narrow, D.S. Rae, R.W. Manderscheid, B.Z. Locke, and F.K. Goodwin The de facto US mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services Arch Gen Psychiatry 50 2 1993 85 94
5. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, and S. Eshelman Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 1 1994 8 19
6. K.M. Carroll, C. Nich, S.A. Ball, E. McCance, and B.J. Rounsaville Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram Addiction 93 5 1998 713 727
7. Institute of Medicine Reducing suicide: a national imperative 2002 National Academies Press Washington (DC)
8. Centers for Disease Control and Prevention. The Sentinel Counties Study of Acute Viral Hepatitis. CDC Hepatitis Surveillance. 2000. Atlanta (GA) US Department of Health and Human Services, Centers for Disease Control and Prevention. Report No. 57.
9. R.S. Garfein, D. Vlahov, N. Galai, M.C. Doherty, and K.E. Nelson Viral infections in short-term injection drug users: the prevalence of the hepatitis c, hepatitis v, human immunodeficiency, and human t-lymphotropic viruses Am J Public Health 86 5 1996 655 661
10. L.E. Sullivan, and D.A. Fiellin Hepatitis C and HIV infections: implications for clinical care in injection drug users Am J Addict 13 1 2004 1 20
11. I. De Alba, J.H. Samet, and R. Saitz Burden of medical illness in drug-and alcohol-dependent persons without primary care Am J Addict 13 1 2004 33 45
12. Coffey RM, Mark T, King E, Harwood H, McKusick D, Genuardi J, et al. National estimates of expenditures for mental health and substance abuse treatment, 1997. 2000, Rockville (MD), Substance Abuse and Mental Health Services Administration, Publication SMA-00-3499.
13. M.J. Larson, M.C. Farrelly, D.I. Hodgkin, K. Miller, J.S. Lubalin, and E. Witt Payments and use of services for mental health, alcohol, and other drug abuse disorders: estimates from Medicare, Medicaid, and private health plans R.W. Manderschied M. Henderson 1998 US Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, US Government Printing Office Washington (DC) 124 141
14. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Drug Abuse Warning Network: detailed emergency department tables. Available at: http://www.samhsa.gov.
15. P.S. Wang, O. Demler, and R.C. Kessler Adequacy of treatment for serious mental illness in the United States Am J Public Health 92 1 2002 92 98
16. R.C. Kessler, C.B. Nelson, K.A. McGonagle, M.J. Edlund, R.G. Frank, and P.J. Leaf The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization Am J Orthopsychiatry 66 1 1996 17 31
17. R.L. Spitzer, J.B. Williams, K. Kroenke, M. Linzer, F.V. deGruy III, and S.R. Hahn Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study JAMA 272 22 1994 1749 1756
18. A.C. Leon, M. Olfson, M.M. Weissman, L. Portera, B.H. Fireman, and R.S. Blacklow Brief screens for mental disorders in primary care J Gen Intern Med 11 7 1996 426 430
19. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th edition, primary care version 1995 American Psychiatric Association Washington (DC)
20. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch Gen Psychiatry 4 1 1961 461 471
21. M. Hamilton The assessment of anxiety states by rating Br J Med Psychol 32 1 1959 50 55
22. M.A. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1 1960 56 62
23. W.W. Zung A self-rating depression scale Arch Gen Psychiatry 12 1 1965 63 70
24. J.A. Ewing Detecting alcoholism. The CAGE questionnaire JAMA 252 14 1984 1905 1907
25. M.L. Selzer The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument Am J Psychiatry 127 12 1971 1653 1658
26. O. Nilssen, and H. Cone Screening patients for alcohol problems in primary health care settings Am J Addict 4 Suppl 1 1996 53 58
27. H.A. Skinner The drug abuse screening test Addict Behav 7 4 1982 363 371
28. J. Westermeyer, I. Yargic, and P. Thuras Michigan Assessment-Screening Test for Alcohol and Drugs (MAST/AD): evaluation in a clinical sample Am J Addict 13 2 2004 151 162